A newly discovered cysteine protease, Prp, has been shown to perform an essential, site-specific cleavage of ribosomal protein L27 in Staphylococcus aureus. In Firmicutes and related bacteria, ribosomal protein L27 is encoded with a conserved N-terminal extension that must be removed to expose residues critical for ribosome function. Uncleavable and pre-cleaved variants were unable to complement an L27 deletion in S. aureus, indicating that this N-terminal processing event is essential and likely plays an important regulatory role. The gene encoding the responsible protease (prp) has been shown to be essential, and is found in all organisms encoding the N-terminal extension of L27. Cleavage of L27 by Prp represents a new target for potential antibiotic therapy. In order to characterize this protease, Prp has been overexpressed and purified. Using an assay we have developed, based on cleavage of a fluorogenic peptide derived from the conserved L27 cleavage sequence, we have undertaken an analysis of the enzyme kinetics and substrate specificity for Prp cleavage and tested predictions made based on a structural model using active-site mutants.

This essay explores how artwork in the public space can be analysed, conceptualized and described by bringing attention to site. Through an analysis of artworks in the yearly art exhibition of Fittja Open 2011, the essay draws attention to site-specific art and structures of power. The principal aim is to present not only the exhibition of Fittja Open 2011 but also other artwork in the public sphere in Fittja, a suburb to Stockholm. From this point of departure other interests evolve that concerns the "image" of Fittja. The analysis, based on research in art history, architecture, ethnology and philosophy as well as qualitative interviews, also focuses on understanding the role of site and the relations between art practice, institutions and site. The result shows that there are problems with a ruptured interface between the artwork and site. The claim made throughout the thesis is that artwork in the public sphere of Fittja need to be sensitive to the conflicted issue of public space in order not to reproduce stereotypes. Despite the knowledge and insight about its local art situation, the study also points out certain insensibility on behalf of Botkyrka konsthall as regards social status and class.

A crisantaspase é uma enzima do tipo asparaginase (ASNase) produzida pela bactéria Erwinia chrysanthemi e utilizada como biofármaco no tratamento da leucemia linfoblástica aguda (LLA) em casos de hipersensibilidade à ASNase de E. coli. As principais desvantagens deste biofármaco são a curta meia-vida (10 horas) e imunogenicidade. Nesse sentido, sua forma peguilada (PEG-crisantaspase) não só reduziria o efeito imunogênico, como também melhoraria a meia-vida plasmática. Atualmente, somente a ASNase de E. coli está disponível comercialmente na forma peguilada e essa, por ter sido uma das primeiras proteínas a serem peguiladas, é resultado de um processo de peguilação aleatória em resíduos de lisina. Portanto, apresenta alto grau de polidispersão em relação à quantidade de cadeias de PEG ligadas à enzima. Nesse trabalho desenvolvemos um processo de obtenção de crisantaspase peguilada de maneira sítio-específica, no grupamento N-terminal (PEG-crisantaspase). A crisantaspase foi obtida de forma recombinante na cepa E. coli BL21, cultivada em agitador metabólico e biorreator, em meio Luria Bertani. A produtividade volumétrica no biorreator aumentou 37% em comparação com o agitador metabólico (460 e 335 U·L-1·h-1 respectivamente). A crisantaspase foi recuperada por choque osmótico e purificada por cromatografia de troca catiônica (coluna HiTrap SP FF, 5 mL, eluição em pH 7,5), apresentando atividade específica de 694 U·mg-1, fator de purificação de 31 e rendimento de 69%. A crisantaspase purificada foi peguilada com mPEG-NHS 10 kDa, em tampão fosfato 100 mM, 22 °C, razão molar enzima:PEG 1:50 durante 30 min e sob diferentes valores de pH (6,5-9,0). O melhor rendimento de peguilação N-terminal (50%) foi em pH 7,5 com menor formação de estruturas poli-peguiladas (7%). A PEG-crisantaspase foi isolada por cromatografia de exclusão molecular, retendo 50% da atividade específica (357 U·mg-1) com valor de kM três vezes maior do que o da crisantaspase (150 e 48,5 µM respectivamente). Entretanto, apresentou maior estabilidade em altas temperaturas. Em duas semanas, a crisantaspase perdeu 93% de sua atividade específica enquanto que a PEG-crisantaspase foi estável por 20 dias. Portanto, a enzima PEG-crisantaspase desenvolvida representa uma alternativa promissora para o tratamento da LLA. / Crisantaspase is an asparaginase enzyme (ASNase) produced by Erwinia chrysanthemi bacterium and used as biopharmaceutical in the treatment of acute lymphoblastic leukemia (ALL) in case of hypersensivity to E. coli ASNase. The main disadvantages of this biopharmaceutical are the short half-life (10 hours) and immunogenicity. In this sense, its PEGylated form (PEG-crisantaspase) could not only reduce the immunogenic effect but also improve plasma half-life. Currently, only E. coli ASNase is commercially available in its pegylated form. Since ASNase was one of the first proteins to be pegylated, it corresponds to a random PEGylation process on lysine residues and consequently preparations are highly polydisperse. In this work we developed a process to obtain a site-specific N-terminal PEGylated crisantaspase (PEG-crisantaspase). Crisantaspase was recombinantly expressed in E. coli BL21 strain, grown in shaker and bioreactor, in Luria Bertani medium. Volumetric productivity in bioreactor increased 37% compared to shaker conditions (460 and 335 U·L-1·h-1 respectively). Crisantaspase was extracted by osmotic shock and purified by cation exchange chromatography (HiTrap SP FF column, 5 mL, elution at pH 7.5), presenting specific activity of 694 U·mg-1,31 purification fold and an yield of 69%. Purified crisantaspase was PEGylated with 10 kDa mPEG-NHS in 100mM phosphate buffer, 22°C, enzyme:PEG molar ratio of 1:50 for 30 min, and at different pH values (6.5-9.0). The highest N-terminal pegylation yield (50%) was at pH 7.5 with less poly-PEGylated forms (7%). PEG-crisantaspase was purified by size-exclusion chromatography, retaining 50% of specific activity (357 U·mg-1) with a kM value 3 times higher than crisantaspase (150 and 48,5 µM respectively). Nonetheless, PEG-crisantaspase was found to be more stable at high temperatures and over the time. In two weeks, crisantaspase lost 93% of its specific activity, while PEG-crisantaspase was stable for 20 days. Therefore, the novel PEG-crisantaspase enzyme developed represents a promising alternative for the treatment of ALL.

A crisantaspase é uma enzima do tipo asparaginase (ASNase) produzida pela bactéria Erwinia chrysanthemi e utilizada como biofármaco no tratamento da leucemia linfoblástica aguda (LLA) em casos de hipersensibilidade à ASNase de E. coli. As principais desvantagens deste biofármaco são a curta meia-vida (10 horas) e imunogenicidade. Nesse sentido, sua forma peguilada (PEG-crisantaspase) não só reduziria o efeito imunogênico, como também melhoraria a meia-vida plasmática. Atualmente, somente a ASNase de E. coli está disponível comercialmente na forma peguilada e essa, por ter sido uma das primeiras proteínas a serem peguiladas, é resultado de um processo de peguilação aleatória em resíduos de lisina. Portanto, apresenta alto grau de polidispersão em relação à quantidade de cadeias de PEG ligadas à enzima. Nesse trabalho desenvolvemos um processo de obtenção de crisantaspase peguilada de maneira sítio-específica, no grupamento N-terminal (PEG-crisantaspase). A crisantaspase foi obtida de forma recombinante na cepa E. coli BL21, cultivada em agitador metabólico e biorreator, em meio Luria Bertani. A produtividade volumétrica no biorreator aumentou 37% em comparação com o agitador metabólico (460 e 335 U·L-1·h-1 respectivamente). A crisantaspase foi recuperada por choque osmótico e purificada por cromatografia de troca catiônica (coluna HiTrap SP FF, 5 mL, eluição em pH 7,5), apresentando atividade específica de 694 U·mg-1, fator de purificação de 31 e rendimento de 69%. A crisantaspase purificada foi peguilada com mPEG-NHS 10 kDa, em tampão fosfato 100 mM, 22 °C, razão molar enzima:PEG 1:50 durante 30 min e sob diferentes valores de pH (6,5-9,0). O melhor rendimento de peguilação N-terminal (50%) foi em pH 7,5 com menor formação de estruturas poli-peguiladas (7%). A PEG-crisantaspase foi isolada por cromatografia de exclusão molecular, retendo 50% da atividade específica (357 U·mg-1) com valor de kM três vezes maior do que o da crisantaspase (150 e 48,5 µM respectivamente). Entretanto, apresentou maior estabilidade em altas temperaturas. Em duas semanas, a crisantaspase perdeu 93% de sua atividade específica enquanto que a PEG-crisantaspase foi estável por 20 dias. Portanto, a enzima PEG-crisantaspase desenvolvida representa uma alternativa promissora para o tratamento da LLA. / Crisantaspase is an asparaginase enzyme (ASNase) produced by Erwinia chrysanthemi bacterium and used as biopharmaceutical in the treatment of acute lymphoblastic leukemia (ALL) in case of hypersensivity to E. coli ASNase. The main disadvantages of this biopharmaceutical are the short half-life (10 hours) and immunogenicity. In this sense, its PEGylated form (PEG-crisantaspase) could not only reduce the immunogenic effect but also improve plasma half-life. Currently, only E. coli ASNase is commercially available in its pegylated form. Since ASNase was one of the first proteins to be pegylated, it corresponds to a random PEGylation process on lysine residues and consequently preparations are highly polydisperse. In this work we developed a process to obtain a site-specific N-terminal PEGylated crisantaspase (PEG-crisantaspase). Crisantaspase was recombinantly expressed in E. coli BL21 strain, grown in shaker and bioreactor, in Luria Bertani medium. Volumetric productivity in bioreactor increased 37% compared to shaker conditions (460 and 335 U·L-1·h-1 respectively). Crisantaspase was extracted by osmotic shock and purified by cation exchange chromatography (HiTrap SP FF column, 5 mL, elution at pH 7.5), presenting specific activity of 694 U·mg-1,31 purification fold and an yield of 69%. Purified crisantaspase was PEGylated with 10 kDa mPEG-NHS in 100mM phosphate buffer, 22°C, enzyme:PEG molar ratio of 1:50 for 30 min, and at different pH values (6.5-9.0). The highest N-terminal pegylation yield (50%) was at pH 7.5 with less poly-PEGylated forms (7%). PEG-crisantaspase was purified by size-exclusion chromatography, retaining 50% of specific activity (357 U·mg-1) with a kM value 3 times higher than crisantaspase (150 and 48,5 µM respectively). Nonetheless, PEG-crisantaspase was found to be more stable at high temperatures and over the time. In two weeks, crisantaspase lost 93% of its specific activity, while PEG-crisantaspase was stable for 20 days. Therefore, the novel PEG-crisantaspase enzyme developed represents a promising alternative for the treatment of ALL.

Chez les bactéries, la ségrégation du chromosome est initiée durant la phase de réplication. Des expériences de time lapse, utilisées pour observer que la dynamique des loci frères durant le cycle cellulaire, montrent que, chez Escherichia coli, les régions sœurs restent colocalisées pour une période significative dans les régions des macrodomaines du chromosome et pour une courte période dans les régions non-structurées. Nous nous sommes posés la question suivante: est ce que l’étape de colocalisation révèle une réelle cohésion entre les chromatides sœurs ? Pour y répondre, nous avons développé un outil génétique, alternatif aux outils de biologie cellulaire, permettant de mesurer la distance entre les chromatides sœurs de manière directe. La fréquence de recombinaison intermoléculaire médiée par la recombinase Cre entre les sites loxP positionnés sur les chromatides sœurs est mesurée pour différentes positions. De cette fréquence, nous avons pu déduire la proximité entre les chromatides sœurs. Nous révélons que les loci frères restent proche l’un de l’autre pour une courte période après la réplication. Nous appelons cette étape la cohésion moléculaire, celle-ci est dépendante du locus considéré. Nous montrons que les facteurs qui favorisent la colocalisation des foci frères n’augmentent pas nécessairement l’habilité des loci frères à recombiner. En effet, la protéine MatP, un acteur de la colocalisation des macrodomaines Ter, n’affecte pas la cohésion entre les deux copies de cette région. La Topoisomérase IV est un facteur essentiel à la ségrégation des chromosomes. En son absence, les chromosomes ne peuvent se ségréger et restent colocalisés dans la cellule. Nous révélons par le test de recombinaison que l’absence de Topoisométase IV dans les cellules provoque une augmentation des interactions entre chromatides sœurs. Au final, nous avons montré que l’étape de cohésion est différente de la colocalisation, que les mécanismes moléculaires diffèrent d’une étape à l’autre et que les liens de précaténation moduleraient la cohésion post-réplicative entre chromatides sœurs. / In bacteria, the segregation of the chromosome is initiated during the replication phase. Time lapse experiments, used to watch the dynamic of loci during cell cycle, showed, in Escherichia coli, that the sister loci remain colocalized for a significant amount of time in the macrodomain regions of the chromosome and for shorter period in the Non Structured regions. We asked the following question: does this colocalization step reveal a real cohesion between the sister chromatids? To answer, we have developed a genetic tool, alternative to cell biology tools, to measure the distance between sister chromatids directly. The frequency of intermolecular recombination mediated by Cre recombinase loxP sites located on sister chromatids was measured for various loci. From this frequency we were able to deduce the proximity of sister chromatids. We revealed that sister loci remained in close proximity for a short period following replication. We called this step molecular cohesion, it is dependent on the considered locus. We showed that factors that promote colocalisation of sister foci do not necessarily increase the ability of sister loci to recombine. Indeed, the MatP protein, an actor of macrodomain Ter colocalisation, does not affect the cohesion between the two copies of this region. The TopoIV is essential for the segregation of chromosomes. In its absence, the chromosomes can not segregate and remain colocalized in the cell. We reveal by recombinaison assy that the absence of Topoisomerase IV revealed an increase of interactions between sister chromatids. To conclude, we have shown that the cohesion step is different from the colocalisation step, the molecular mechanisms differ from one stage to another and précaténation links take part in the post-replicative cohesion between sister chromatids

La majorité des ADC qui sont actuellement en clinique et en développement sont produits par une conjugaison chimique via les résidus lysine ou cystéine, menant à un produit hétérogène pour leur ratio toxine sur anticorps (DAR). L'objet des travaux de thèse a pour but de décrire la caractérisation in vitro et in vivo de nouveaux ADC optimisés et construits à partir de l'anticorps anti-CD30 cAC10, ayant le même squelette polypetidique que Adcetris, et de comparer les résultats à ce dernier. La transglutaminase bactérienne (BTG) a été utilisée pour conjuguer de manière site-spécifique la MMAE aux glutamines aux positions 295 et 297 du cAC10, amenant à des ADCs homogènes de DAR 4, TG-ADC. Des travaux préliminaires ont permis d’établir les conditions optimales de conjugaison avec un procédé en deux étapes. Les tests de cytotoxicité ont révélé des EC50 comparables entre Adcetris et les TG-ADC. Les données d’efficacité in vivo montrent une efficacité équivalente voire légèrement supérieure pour les TG-ADC que Adcetris. L'étude de biodistribution in vivo dans un modèle avec et sans tumeur est réalisé avec un 125-I TG-ADC et est comparé à 125I-Adcetris. Le TG ADC site spécifique montre une meilleure distribution tumorale. Adcetris a une distribution non médiée par la cible, dans le foie et la rate, plus importante. En ligne avec ces résultats, la dose maximale tolérée des TG ADC est significativement plus élevée que Adcetris chez le rat. Ces résultats suggèrent que les ADC homogènes ont une meilleure pharmacocinétique et un meilleur index thérapeutique comparés aux ADC avec des DAR hétérogènes. / Most ADC that are currently in clinical use or development produced by chemical conjugation of a toxin via either lysine or cysteine residues, inevitably leading to heterogeneous products with variable drug-to-antibody ratios (DARs). Here, we describe the in vitro and in vivo characterization of novel ADCs that are based on the anti-CD30 antibody cAC10, which has the same polypeptide backbone as Adcetris, and compare the results with the latter. Bacterial transglutaminase (BTG) was exploited to site-specifically conjugate derivatives of MMAE to the glutamines at position 295 and 297 of cAC10, yielding homogeneous ADCs with a DAR of 4, TG-ADC. Preliminary works have led to define optimal conditions for conjugation, but also define a two step process. In vitro cell toxicity experiments revealed comparable EC50-values for Adcetris and TG-ADC. The efficacy data have shown slightly better efficacy for TG-ADC compared to Adcetris. Quantitative time-dependent in vivo biodistribution studies in normal and xenografted mice were performed with a selected 125I TG ADC and compared with 125I-Adcetris. Adcetris has an higher liver and spleen unspecific uptakes. In line with these results, the maximum tolerated dose of the BTG-coupled ADC (> 60 mg/kg) was significantly higher than that of ADCETRIS® (18 mg/kg) in rats. These results suggest that homogenous ADCs display improved pharmacokinetics and better therapeutic indexes compared to chemically modified ADCs with variable DARs.

<p>Risk assessment is made to determine risks with contaminated areas and to determine which treatment the area requires. In Sweden, risk assessment is divided into three levels: risk analysis, facilitated risk assessment and detailed risk assessment. In detailed risk assessment site-specific guideline values are developed to compare with values of contaminants that are measured in the area.</p><p>Site-specific guideline values vary with geological and hydrogeological parameters. The purpose of this report is to examine which of these parameters that affect the guideline values. The examination was done using a calculating program for consideration from the Swedish Environmental Protection Agency from the year of 1997. The study shows that some of the geological and hydrogeological parameters affect the site-specific guideline values for metals in different ways and others do not.  </p><p>Using the program from the Swedish Environmental Protection Agency is a simple way to calculate site-specific guideline values. It’s important to make sure that relevant values are chosen to get correct results. The calculating program is still not definitive so it’s important to be careful when using it.</p><p>Another purpose of the report is to compare how guideline values have developed from the Swedish Environmental Protection Agency’s model for calculating guideline values from the year of 1997 with their new report whit the same purpose from the year of 2007. Guideline values for all metals that have been considered are lower in the new model from the year of 2007 compared to the model from the year of 1997.</p>

<p>The glutathione transferases (GSTs) represent a superfamily of dimeric proteins involved in cellular detoxication by catalyzing the nucleophilic addition of the reduced glutathione (GSH) to the hydrophobic electrophiles. The present work focuses on the functional role of the conserved structures of GSTP1-1. The lock-and-key motif is a highly conserved hydrophobic interaction in the subunit interface of Pi, Mu, and Alpha class GSTs. The key residue (Tyr⁵⁰ in hGSTP1-1) of one subunit is wedged into a hydrophobic pocket of the neighboring subunit. The heterodimer GSTP1/Y50A was constructed from the fully active wild-type GSTP1-1 and the nearly inactive Y50A in order to study how an essentially inactive subunit influences the activity of the neighboring subunit. The results illuminate the vital role of the lock-and-key motif in modulating the GSH binding and the rate of catalysis. Additionally, the two active sites of the dimeric enzyme work synergistically. An observed water network, in hGSTP1-1 structures, connects the two active sites, thereby offering a mechanism for communication between the two active sites.</p><p>Cys⁴⁸ and Tyr⁵⁰ were targeted by mutations and chemical modifications for understanding how the α2 loop residues modulate GSH binding and catalysis. The replacement of Tyr⁵⁰ with different unnatural amino acids showed that the nature of the key residue side-chain influences the interaction with the lock structure and, consequently, the catalytic activity. The K_M^GSH, GSH affinity and protein stability can be modulated by fitting key residue into the lock cavity of the neighbor subunit and, consequently, restriction of the flexibility of the α2 loop. Optimization of the interaction between the key residue and the lock-cavity increases k_cat. Also, the crystal structure of the Cys-free variant was determined. The result indicated that Cys⁴⁸ restricts the flexibility of the α2 loop by interacting with surrounding residues and, consequently, contributes to GSH binding and protein stability.</p>

The glutathione transferases (GSTs) represent a superfamily of dimeric proteins involved in cellular detoxication by catalyzing the nucleophilic addition of the reduced glutathione (GSH) to the hydrophobic electrophiles. The present work focuses on the functional role of the conserved structures of GSTP1-1. The lock-and-key motif is a highly conserved hydrophobic interaction in the subunit interface of Pi, Mu, and Alpha class GSTs. The key residue (Tyr50 in hGSTP1-1) of one subunit is wedged into a hydrophobic pocket of the neighboring subunit. The heterodimer GSTP1/Y50A was constructed from the fully active wild-type GSTP1-1 and the nearly inactive Y50A in order to study how an essentially inactive subunit influences the activity of the neighboring subunit. The results illuminate the vital role of the lock-and-key motif in modulating the GSH binding and the rate of catalysis. Additionally, the two active sites of the dimeric enzyme work synergistically. An observed water network, in hGSTP1-1 structures, connects the two active sites, thereby offering a mechanism for communication between the two active sites. Cys48 and Tyr50 were targeted by mutations and chemical modifications for understanding how the α2 loop residues modulate GSH binding and catalysis. The replacement of Tyr50 with different unnatural amino acids showed that the nature of the key residue side-chain influences the interaction with the lock structure and, consequently, the catalytic activity. The KMGSH, GSH affinity and protein stability can be modulated by fitting key residue into the lock cavity of the neighbor subunit and, consequently, restriction of the flexibility of the α2 loop. Optimization of the interaction between the key residue and the lock-cavity increases kcat. Also, the crystal structure of the Cys-free variant was determined. The result indicated that Cys48 restricts the flexibility of the α2 loop by interacting with surrounding residues and, consequently, contributes to GSH binding and protein stability.

This thesis describes how the human Alpha class glutathione transferase (GST) A1-1 can be reprogrammed either to function as a multipurpose biosensor for detection of small molecule analytes, or as a handle providing for more efficient protein purification. A novel, user-friendly, and efficient method for site-specific introduction of functional groups into the active site of hGST A1-1 is the platform for these achievements. The designed thioester reagents are glutathione-based and they are able to label one single nucleophile (Y9) and leave the other 50 nucleophiles (in hGST A1-1) intact. The modification reaction was tested with five classes of GSTs (Alpha, Mu, Pi, Theta and Omega) and was found to be specific for the Alpha class isoenzymes. The reaction was further refined to target a single lysine residue, K216 in the hGST A1-1 mutant A216K, providing a stable amide bond between the protein and the labeling group. To further improve the labeling process, biotinylated reagents that could deliver the acyl group to Y9 (wt hGST A1-1) or K216 in the lysine mutant, while attached to streptavidin-coated agarose beads, were designed and synthesized. A focused library of eleven A216K/M208X mutants was made via random mutagenesis to provide an array of proteins with altered micro-environments in the hydrophobic binding site, where M208 is situated. Through the invented route for site-specific labeling, a fluorescent probe (coumarin) was introduced on K216 in all double mutants, with the purpose of developing a protein-based biosensor, akin to the olfactory system. The array of coumarin-labeled proteins responded differently to the addition of different analytes, and the responses were analyzed through pattern recognition of the fluorescence signals. The labeled proteins could also be site-specifically immobilized on a PEG-based biosensor chip via the single C112 on the surface of the protein, enabling development of surface-based biosensing systems. Also, a refined system for efficient detection and purification of GST-fusion proteins is presented. Through a screening process involving A216K and all produced A216K/M208X mutants, two candidates (A216K and A216K/M208F) were singled out as scaffolds for the next generation of fusion proteins. In addition to the features present in commercially available GST fusion constructs, the new mutants can be site-specifically labeled with a fluorophore in bacterial lysates providing quick and sensitive monitoring of expression and purification. Furthermore, the proteins could be labeled with a unique aldehyde moiety providing for a novel protein purification scheme.